Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia

  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Ferrer Oliveras, Albert
  • Ribera Salas, Jordi|||0000-0003-4796-6470
  • Genescà, Eulàlia|||0000-0002-5657-4842
The CD19 marker is expressed on the surface of normal and malignant immature or mature B-cells. On the other hand, immunotherapy involving T-cells is a promising modality of treatment for many neoplastic diseases including leukemias and lymphomas. The CD19/CD3-bispecific T-cell-engaging (BiTE ®) monoclonal antibody blinatumomab can transiently engage cytotoxic T-cells to CD19+ target B-cells inducing serial perforin-mediated lysis. In the first clinical trial, blinatumomab showed efficacy in non-Hodgkin's lymphomas, but the most important trials have been conducted in relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) and in ALL with minimal residual disease. Encouraging reports on the activity of blinatumomab in R/R Philadelphia chromosome-negative B-cell precursor ALL led to its approval by the US Food and Drug Administration on December 3, 2014 after an accelerated review process. This review focuses on the profile of blinatumomab and its activity in R/R ALL.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features

  • Palomo Sanchís, Laura|||0000-0003-3176-6271
  • García, Olga
  • Arnan, Montserrat
  • Xicoy, Blanca|||0000-0002-0295-1307
  • Fuster García, Francisco|||0000-0002-2528-6143
  • Cabezón, Marta|||0000-0001-5122-7481
  • Coll, Rosa|||0000-0003-0560-1254
  • Ademà, Vera|||0000-0001-6051-4378
  • Grau Cat, Javier
  • Jiménez, Maria-José
  • Pomares, Helena
  • Marcé, Silvia|||0000-0001-9128-6822
  • Mallo, Maria del Mar|||0000-0001-7741-498X
  • Millá, Fuensanta
  • Alonso, Esther
  • Sureda, Anna|||0000-0002-1238-6970
  • Gallardo, David|||0000-0003-1615-4592
  • Feliu Frasnedo, Evarist|||0000-0001-5780-3136
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Sole, F.|||0000-0002-3251-2161
  • Zamora, Lurdes|||0000-0003-1713-7110
Clonal cytogenetic abnormalities are found in 20-30% of patients with chronic myelomonocytic leukemia (CMML), while gene mutations are present in.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia

  • Anadón, C.
  • van Tetering, G.
  • Ferreira, H. J.
  • Moutinho, Catia|||0000-0003-3885-0847
  • Martínez Cardús, Anna|||0000-0002-3937-8794
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Soler, Marta|||0000-0002-6656-957X
  • Heyn, Holger|||0000-0002-3276-1889
  • Moran, S.|||0000-0003-4192-8983
  • Castro de Moura, Manuel|||0000-0002-8488-5306
  • Setien, F.
  • Vidal, A.
  • Genescà, Eulàlia|||0000-0002-5657-4842
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Guil, Sonia|||0000-0002-2257-3331
  • Esteller, M.|||0000-0003-4490-6093
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine

  • Cabezón, Marta|||0000-0001-5122-7481
  • Bargay, Joan|||0000-0002-6739-3916
  • Xicoy, Blanca|||0000-0002-0295-1307
  • García, Olga
  • Borrás, Josep
  • Tormo, Mar|||0000-0001-9622-1649
  • Marcé, Silvia|||0000-0001-9128-6822
  • Pedro, Carme
  • Valcárcel, David|||0000-0002-8747-078X
  • Jiménez, Maria José
  • Guàrdia, Ramón
  • Palomo Sanchís, Laura|||0000-0003-3176-6271
  • Brunet, Salut|||0000-0003-0491-1672
  • Vall-Llovera, Ferran|||0000-0002-0718-5955
  • Garcia-Guiñon, Antonio|||0000-0003-0006-4162
  • Feliu Frasnedo, Evarist|||0000-0001-5780-3136
  • Zamora, Lurdes|||0000-0003-1713-7110
Myelodysplastic syndromes (MDS) are stem cell disorders caused by various gene abnormalities. We performed targeted deep sequencing in 39 patients with high-risk MDS and secondary acute myeloid leukemia (sAML) at diagnosis and follow-up (response and/or relapse), with the aim to define their mutational status, to establish if specific mutations are biomarkers of response to 5-azacytidine (AZA) and/or may have impact on survival. Overall, 95% of patients harbored at least one mutation. TP53, DNMT3A and SRSF2 were the most frequently altered genes. Mutations in TP53 correlated with higher risk features and shorter overall survival (OS) and progression free survival (PFS) in univariate analysis. Patients with SRSF2 mutations were associated with better OS and PFS. Response rate was 55%; but we could not correlate the presence of TET2 and TP53 mutations with AZA response. Patients with sAML presented more variations than patients with high-risk MDS, and usually at relapse the number of mutations increased, supporting the idea that in advanced stages of the disease there is a greater genomic complexity. These results confirm that mutation analysis can add prognostic value to high-risk MDS and sAML patients, not only at diagnosis but also at follow-up.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia

  • Genescà, Eulàlia|||0000-0002-5657-4842
  • Lazarenkov, Aleksey|||0000-0003-0652-8116
  • Morgades, Mireia|||0000-0003-0295-2534
  • Berbis, G.
  • Ruíz-Xivillé, Neus
  • Gómez-Marzo, Paula|||0000-0002-6829-9630
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Junca, Jordi|||0000-0003-0142-772X
  • Gonzalez-Perez, Abel|||0000-0002-8582-4660
  • Mercadal, Santiago|||0000-0003-4741-7885
  • Guàrdia, Ramón
  • Artola, Maria Teresa
  • Moreno, Maria José
  • Martínez-López, Joaquín F.
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Barba, Pere|||0000-0001-7076-7969
  • Gil, Cristina
  • Tormo, Mar|||0000-0001-9622-1649
  • Cladera, Antonia
  • Novo, Andrés
  • Pratcorona, Marta|||0000-0001-6375-596X
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • González Campos, José
  • Almeida Parra, María
  • Cervera, José|||0000-0001-8252-1106
  • Montesinos, Pau|||0000-0002-3275-5593
  • Batlle, Montserrat|||0000-0002-3034-2023
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Esteve Reyner, Jordi|||0000-0002-8056-648X
  • Feliu Frasnedo, Evarist|||0000-0001-5780-3136
  • Sole, F.|||0000-0002-3251-2161
  • Orfao, Alberto|||0000-0002-0007-7230
  • Ribera, Jose-Maria|||0000-0003-1042-6024
Recurrent deletions of the CDKN2A/ARF/CDKN2B genes encoded at chromosome 9p21 have been described in both pediatric and adult acute lymphoblastic leukemia (ALL), but their prognostic value remains controversial, with limited data on adult T-ALL. Here, we investigated the presence of homozygous and heterozygous deletions of the CDKN2A/ARF and CDKN2B genes in 64 adult T-ALL patients enrolled in two consecutive trials from the Spanish PETHEMA group. Alterations in CDKN2A/ARF/CDKN2B were detected in 35/64 patients (55%). Most of them consisted of 9p21 losses involving homozygous deletions of the CDKNA/ARF gene (26/64), as confirmed by single nucleotide polymorphism (SNP) arrays and interphase fluorescence in situ hybridization (iFISH). Deletions involving the CDKN2A/ARF/CDKN2B locus correlated with a higher frequency of cortical T cell phenotype and a better clearance of minimal residual disease (MRD) after induction therapy. Moreover, the combination of an altered copy-number-value (CNV) involving the CDKN2A/ARF/CDKN2B gene locus and undetectable MRD (≤ 0.01%) values allowed the identification of a subset of T-ALL with better overall survival in the absence of hematopoietic stem cell transplantation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia

  • Genescà, Eulàlia|||0000-0002-5657-4842
  • Morgades, Mireia|||0000-0003-0295-2534
  • Montesinos, Pau|||0000-0002-3275-5593
  • Barba, Pere|||0000-0001-7076-7969
  • Gil, Cristina
  • Guàrdia, Ramón
  • Moreno, Maria José
  • Martínez-Carballeira, Daniel|||0000-0003-4840-7822
  • García Cadenas, Irene|||0000-0002-2994-9055
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Ribera Salas, Jordi|||0000-0003-4796-6470
  • González Campos, José
  • González Gil, Celia|||0000-0002-7582-1482
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Ramirez, Jose Luis
  • Díaz-Beyá, Marina|||0000-0001-9624-2597
  • Mercadal, Santiago|||0000-0003-4741-7885
  • Artola, Maria Teresa
  • Cladera, Antonia
  • Tormo, Mar|||0000-0001-9622-1649
  • Bermúdez, Arancha
  • Vall-Llovera, Ferran|||0000-0002-0718-5955
  • Martínez Sánchez, Pilar|||0000-0002-7334-140X
  • Amigo, María-Luz|||0000-0002-3356-9290
  • Monsalvo, Silvia
  • Novo, Andrés
  • Cervera, Marta
  • Garcia-Guiñon, Antonio|||0000-0003-0006-4162
  • Junca, Jordi|||0000-0003-0142-772X
  • Ciudad Pizarro, Juana
  • Orfao, Alberto|||0000-0002-0007-7230
  • Ribera, Jose-Maria|||0000-0003-1042-6024